Clorox (CLX, Financial) has recently seen a reduction in its price target as announced by Jefferies analyst Kaumil Gajrawala on June 26, 2025. The price target has been adjusted from $167.00 to $145.00, marking a 13.17% decrease.
Despite the lowered price target, the analyst has maintained a "Buy" rating on Clorox (CLX, Financial). Previously, the stock also held a "Buy" rating, indicating continued confidence in the company's performance despite the adjustment in expected valuation.
For investors focusing on Clorox (CLX, Financial), this adjustment suggests a recalibration of market expectations while still affirming long-term potential as indicated by the maintained rating.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 17 analysts, the average target price for Clorox Co (CLX, Financial) is $147.54 with a high estimate of $189.00 and a low estimate of $119.00. The average target implies an upside of 23.48% from the current price of $119.48. More detailed estimate data can be found on the Clorox Co (CLX) Forecast page.
Based on the consensus recommendation from 21 brokerage firms, Clorox Co's (CLX, Financial) average brokerage recommendation is currently 3.0, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Clorox Co (CLX, Financial) in one year is $144.34, suggesting a upside of 20.81% from the current price of $119.48. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Clorox Co (CLX) Summary page.
